Reflections on the gene patent war: The myriad battle, sputnik and beyond

Clinical Chemistry

Volumn 57, Issue 7, 2011, Pages 977-979

  Caulfield, Timothy ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

BREAST CANCER; DNA SEQUENCE; GENE; GENE MUTATION; GENE PATENT; GENETIC ANALYSIS; GENETICS; GENOMICS; HUMAN; MEDICAL RESEARCH; NOTE; PATENT; POLICY; WAR;

BASE SEQUENCE; DNA; GENETICS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PATENTS AS TOPIC; PUBLIC OPINION; RESEARCH;

EID: 79959733175     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.162313     Document Type: Note

References (17)

1. Crichton M. Patenting life. New York Times 2007 Feb 13.
2. American Civil Liberties Union. BRCA - Amicus brief: E. Richard Gold, James P. Evans, and Tania Bubela. http://www.aclu.org/free-speech-womens-rights/ brca-amicus-brief-e-richard-gold-james-p-evans-and-tania-bubela (Accessed March 2011).
3. Frankel A. U.S. Solicitor General to make unprecedented federal circuit appearance in Myriad case. The American Lawyer 2011 Feb 24.
4. Cho MK, Illangasekare S, Weaver MA, Leonard DGB, Merz JF. Effects of patents and licenses on the provision of clinical genetic testing services. J Mol Diagn 2003;5:3-8. (Pubitemid 36192993)
5. Walsh JP, Cho C, Cohen WM. Patents, material transfers and access to research inputs in biomedical research. Final report to the National Academy of Sciences' Committee Intellectual Property Rights in Genomic and Protein-Related Inventions. 2005 Sep 20. http://www2.druid.dk/conferences/viewpaper.php?id= 776&cf=8 (Accessed March 2011).
6. American Association for the Advancement of Science (AAAS). International intellectual property experiences: a report of four countries. 2007. http://sippi.aaas.org/Pubs/SIPPI-Four-Country-Report.pdf (Accessed March 2011).
7. Murdoch CJ, Caulfield T. Commercialization, patenting and genomics: researcher perspectives. Genome Med 2009;1:22.
8. Huys I, Berthels N, Matthijs G, Van Overwalle G. Legal uncertainty in the area of genetic diagnostic testing. Nat Biotechnol 2009;27:903-9.
9. Hawkins N. The impact of human gene patents on genetic testing in the United Kingdom. Genet Med 2011;13:320-4.
10. Holman C. The impact of human gene patents on innovation and access: a survey of human gene patent litigation. UMKC Law Rev 2007;76:295-361.
11. Van Overwalle G. Intellectual property. Turning patent swords into shares. Science 2010;330:1630-1.
12. Cho M. Patently unpatentable: implications of the Myriad court decision on genetic diagnostics. Trends Biotechnol 2010;28:548-51.
13. Williams HL. Intellectual property rights and innovation: evidence from the human genome. Working Paper 16213. Cambridge (MA): National Bureau of Economic Research; 2010 Jul. http://www.nber.org/papers/w16213 (Accessed March 2011).
14. Skeehan K, Heaney C, Cook-Deegan R. Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease. Genet Med 2010;12:S71-82.
15. Chandrasekharan S, Cook-Deegan R. Gene patents and personalized medicine - What lies ahead? Genome Med 2009;1:92.
16. Hong W, Walsh J. For money or glory? Commercialization, competition, and secrecy in the entrepreneurial university. Sociol Q 2009;50:145-71.
17. Bubela T, Strotmann A, Adams R, Morrison S. Commercialization and collaboration: competing policies in publicly funded stem cell research? Cell Stem Cell 2010;7:25-30.